SynthesisBMC pulmonary medicine2025

Efficacy and safety of anlotinib combined with immune checkpoint inhibitors in the treatment of extensive-stage small cell lung cancer: a meta-analysis based on real-world data.

Yuying Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.